Back to search
FDAFDA · Food and drugs·Recall number D-091-2013

Enjuvia (synthetic conjugated estrogens, B) tablets, 0.625 mg, 30-count tablets per bottle, Rx only, Mfg. By: Teva Pharmaceuticals USA, Sellersville PA 18960; Repacked & distributed by: Physicians Total Care, Inc., Tulsa, OK 74146; NDC 54868-6163-1.

Published December 19, 2012 · Recall initiated: April 8, 2011

Summary

FDA records drug Class III recall D-091-2013, published December 19, 2012 and initiated April 8, 2011. Recalling firm: Physicians Total Care, Inc.; Status: Terminated; Reported quantity: 9 bottles; Lot: Lot #: 62QI, Exp 01/12; 6DYQ, Exp 08/12. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent (Single ingredient) drug : This is a sub recall of Teva's Enjuvia due to low Out of Specification (OOS) assay results.

What to do

Voluntary: Firm initiated · FAX

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Physicians Total Care, Inc.
Distributor
VA
Lot
Lot #: 62QI, Exp 01/12; 6DYQ, Exp 08/12
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Enjuvia (synthetic conjugated estrogens, B) tablets, 0.625 mg, 30-count tablets per bottle, Rx only, Mfg. By: Teva Pharmaceuticals USA, Sellersville PA 18960; Repacked & distributed by: Physicians Total Care, Inc., Tulsa, OK 74146; NDC 54868-6163-1. recalled?

Yes. FDA published recall D-091-2013 on December 19, 2012. Reported hazard: Subpotent (Single ingredient) drug : This is a sub recall of Teva's Enjuvia due to low Out of Specification (OOS) assay results.

What should I do if I have this product?

Voluntary: Firm initiated · FAX